RE:RE:CIBC TODAYThey will re-evaluate their position, for sure.
All the rules in Europe are known by AMCo, for Concordia is not hard to understand them because they operate there by AMCo. It is not a new market!
If I understand well, they are waiting the Consolidated Financial Statements to raise the target or not.
In this case, they are not able to offer us an information.
<Concordia stock will largely reflect the performance of AMCo. We will re-evaluate our position once we gain more clarity on AMCo's drug portfolio, confidence on management's ability to grow a newly acquired business that operates primarily in Europe, and comfort that AMCo can provide the growth that Concordia expects.>